Research Directory

Step up the fight against superbugs, says EU

Read more

European Commission highlights access, supply in pharma proposal

Read more

Development timelines for new oncology drugs

Read more

Swiss companies weather the turmoil in 2022

Read more

HIV vaccine remains elusive but antivirals deliver value

Read more

FDA guides on accelerated approvals in oncology

Read more

Stock values decline and companies restructure

Read more

Oncology pipeline marked by multiple therapy types

Read more

After three years of Covid, risks to health remain

Read more

Novel oncology drugs approved in a year of change

Read more